Zika Virus Envelope (E) Protein Antibody

The new Zika Virus Envelope (E) Protein Antibody from Kerafast, Inc. is a human serum specimen containing polyclonal antibodies induced by natural infection with the Zika virus. The antibody recognizes and reacts with the E protein of human Zika virus, as determined by binding in ELISA to a recombinant form of the E protein’s extracellular domain. Suitable for both ELISA and virus neutralization applications, the Zika virus antibody was developed by Vanderbilt University researchers, who chose to make the new antibody commercially available for scientists worldwide to help accelerate research related to the Zika virus outbreak.

Kerafast, Inc., (617) 336-3228, www.kerafast.com